This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faure, K.
Right arrow Articles by Wiener-Kronish, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faure, K.
Right arrow Articles by Wiener-Kronish, J. P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2003, p. 2158-2160, Vol. 41, No. 5
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.5.2158-2160.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

O-Antigen Serotypes and Type III Secretory Toxins in Clinical Isolates of Pseudomonas aeruginosa

Karine Faure,1 David Shimabukuro,1 Temitayo Ajayi,1,2 Leonard R. Allmond,1 Teiji Sawa,1 and Jeanine P. Wiener-Kronish1,2,3*

Department of Anesthesia and Perioperative Care,1 Department of Medicine,3 Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 941432

Received 30 September 2002/ Returned for modification 13 November 2002/ Accepted 24 January 2003

The association of O-antigen serotypes with type III secretory toxins was analyzed in 99 clinical isolates of Pseudomonas aeruginosa. Isolates secreting ExoU were frequently serotyped as O11, but none were serotype O1. Most of the isolates that were nontypeable for O antigen did not secrete type III secretory toxins.

* Corresponding author. Mailing address: 513 Parnassus, S-261, Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA 94143-0542. Phone: (415) 476-8968. Fax: (415) 476-8841. E-mail: wienerkj{at}anesthesia.ucsf.edu.

Journal of Clinical Microbiology, May 2003, p. 2158-2160, Vol. 41, No. 5
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.5.2158-2160.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • King, J. D., Kocincova, D., Westman, E. L., Lam, J. S. (2009). Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Innate Immunity 15: 261-312 [Abstract]  
  • Choy, M. H., Stapleton, F., Willcox, M. D. P., Zhu, H. (2008). Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis. J Med Microbiol 57: 1539-1546 [Abstract] [Full Text]  
  • Scarff, J. M., Goldberg, J. B. (2008). Vaccination against Pseudomonas aeruginosa Pneumonia in Immunocompromised Mice. CVI 15: 367-375 [Abstract] [Full Text]  
  • DiGiandomenico, A., Rao, J., Harcher, K., Zaidi, T. S., Gardner, J., Neely, A. N., Pier, G. B., Goldberg, J. B. (2007). Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections. Proc. Natl. Acad. Sci. USA 104: 4624-4629 [Abstract] [Full Text]  
  • Kulasekara, B. R., Kulasekara, H. D., Wolfgang, M. C., Stevens, L., Frank, D. W., Lory, S. (2006). Acquisition and Evolution of the exoU Locus in Pseudomonas aeruginosa. J. Bacteriol. 188: 4037-4050 [Abstract] [Full Text]  
  • Winstanley, C., Kaye, S. B, Neal, T. J, Chilton, H. J, Miksch, S., Hart, C A., and the Microbiology Ophthalmic Group, (2005). Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis. J Med Microbiol 54: 519-526 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»